Financial Review: Resonate Blends (OTCMKTS:KOAN) vs. Envista (NYSE:NVST)

Resonate Blends (OTCMKTS:KOAN) and Envista (NYSE:NVST) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for Resonate Blends and Envista, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Resonate Blends	0	0	0	0	0.00
Envista	0	8	7	0	2.47

Envista has a consensus target price of $27.58, suggesting a potential upside of 0.78%. Given Envista’s stronger consensus rating and higher possible upside, analysts plainly believe Envista is more favorable than Resonate Blends.

Volatility & Risk

Resonate Blends has a beta of 3.73, indicating that its share price is 273% more volatile than the S&P 500. Comparatively, Envista has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500.

Insider and Institutional Ownership

7.4% of Resonate Blends shares are held by institutional investors. 50.0% of Resonate Blends shares are held by insiders. Comparatively, 0.7% of Envista shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Resonate Blends and Envista’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Resonate Blends	-119.97%	N/A	-145.48%
Envista	1.73%	6.54%	3.60%

Valuation & Earnings

This table compares Resonate Blends and Envista”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Resonate Blends	$1.90 million	0.31	-$2.13 million	($0.01)	-0.20
Envista	$2.72 billion	1.64	$47.00 million	$0.28	97.75

Envista has higher revenue and earnings than Resonate Blends. Resonate Blends is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Summary

Envista beats Resonate Blends on 11 of the 14 factors compared between the two stocks.

About Resonate Blends

Resonate Blends, Inc., a cannabis holding company, provides cannabis wellness lifestyle products. The company offers Calm to quiet the mind and ease into a gentle sense of wellbeing; Wonder, a THC offering to bring back the youthful sense; Love to reduce barriers to intimacy, stimulate personal connections, and increase tactile sensation; Create to stimulate senses, spark imagination, and channel inner muse; Play to become fully immersed in the moment and the people around; Delight to open up senses; and Sleep for helping to fall asleep. The company was formerly known as Textmunication Holdings, Inc. and changed its name to Resonate Blends, Inc. in December 2019. Resonate Blends, Inc. is based in Calabasas, California.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.